ASTS applauds the Centers for Medicare and Medicaid Services for the elimination of outcomes requirements as a condition of transplant center re-approval.
The President-Elect and Councilor election results were announced at the ASTS Annual Business Meeting on June 2, 2019. Dr. Marwan Abouljoud, MD, CPE, FACS, is the new president-elect, and the new councilors are Matthew Cooper, MD, Ryutaro Hirose, MD, and Kenneth Washburn, MD.
ASTS joins HRSA in recognizing hospitals, transplant centers, and donation organizations for national organ donation efforts in the 2019 Workplace Partnership for Life Hospital Organ Donation Campaign.
Recognize your trainees, peers, or mentors for their dedication and contributions to the field by nominating them for one of our 6 awards! This year, we are pleased to announce a new Pipeline Award that is designed to recognize an individual who has been influential in the development of medical students or residents through outreach, clinical engagement, or research efforts.
As we celebrate the 20th anniversary of the Winter Symposium in 2020, ASTS is focusing the Winter Symposium on honoring the last 20 years of transplantation and forging ahead through the technologies and advancements that will define the next 20 years.
On July 10, President Trump announced the launch of the Advancing American Kidney Health, a new initiative focused on three goals: fewer patients developing kidney failure, fewer Americans receiving dialysis in dialysis centers, and more kidneys available for transplant.
The Executive Director (ED) is responsible for the overall strategic planning, management and activities of collaborative research endeavors with various stakeholders to accomplish objectives of the Transplant Therapeutics Consortium.
The 2020 Accreditation and Reaccreditation Application is now open! All new programs must apply for accreditation by August 1, 2019 and all accredited programs applying for reaccreditation must submit an application by September 16, 2019.